Keywords: microgenesys, aids, vaccine, future, doubt, highly-touted, gp160-based

MicroGeneSys' AIDS Vaccine Future Is In Doubt

Article | 29 April 1996

MicroGeneSys' highly-touted gp160-based AIDS vaccine, VaxSyn, "did not demonstrate statistically-significant clinical benefit" in a study conducted by researchers at ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Wyeth

Go to company listing